Fundraising Fox

Bluejay Therapeutics

San Mateo, US · Founded 2019 · Delaware corporation · 11 employees on LinkedIn · 10 known investors

Healthcare company acquired by Mirum Pharmaceuticals, a former RiverVest portfolio company.

Founders & leadership

Bluejay Therapeutics was founded in 2019 by Keting Chu.

KC
Keting ChuFounder
DY
Dajun YangNamed on SEC filing
NH
Nancy HongNamed on SEC filing
AL
Alon LazarusNamed on SEC filing
WJ
William J. RutterNamed on SEC filing
TJ
Ting JiaNamed on SEC filing
WC
Wen ChenNamed on SEC filing

Investors · 10

Frazier Life SciencesPalo Alto
RA CapitalBoston
RiverVest Venture PartnersSt. Louis · $500K – $3M
HBM Healthcare InvestmentsreportedZug
Novo HoldingsreportedCopenhagen · $1.1M – $54M
T. Rowe PricereportedBaltimore
Wellington ManagementreportedBoston · $5M – $50M

Also in the syndicate · 3

Arkin Bio VenturesOctagon CapitalUnicorn Capital

Reported raises · per SEC filings

Form D private placements

$221.7M disclosed across 3 rounds · 2021–2024

▶$182MraisedMay 2024 · 19 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Dan EstesDirector
  • Pascal KroteeDirector
  • Jianqing LiDirector
  • Keting ChuExecutive Officer, Director
  • Alon LazarusDirector
  • Dajun YangDirector
Offering amount
$182M
Amount sold
$182M
First sale
May 2024
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$20.5MraisedAug 2022 · 9 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Keting ChuExecutive Officer, Director
  • Dajun YangDirector
  • Nancy HongDirector
  • Alon LazarusDirector
  • William J. RutterDirector
  • Ting JiaDirector
  • Wen ChenDirector
Offering amount
$41.2M
Amount sold
$20.5M
First sale
Aug 2022
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$19.2MraisedJun 2021 · 6 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Keting ChuExecutive Officer, Director
Offering amount
$24.2M
Amount sold
$19.2M
First sale
Jun 2021
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Bluejay Therapeutics Secures $182 Million in Series C Financing to Propel Clinical Pipelineglobenewswire.com · May 2024Bluejay Therapeutics Raises $182M in Series C Financingfinsmes.com · May 2024Bluejay Therapeutics raises $41 million in Series B round to drive clinical trials in chronic hepatitisglobenewswire.com · Aug 2022

Frequently asked questions

What does Bluejay Therapeutics do?
Healthcare company acquired by Mirum Pharmaceuticals, a former RiverVest portfolio company.
Who founded Bluejay Therapeutics?
Bluejay Therapeutics was founded by Keting Chu in 2019.
Who are Bluejay Therapeutics's investors?
Bluejay Therapeutics's investors include Frazier Life Sciences, RA Capital, RiverVest Venture Partners, HBM Healthcare Investments, Novo Holdings, T. Rowe Price, Wellington Management.
How much funding has Bluejay Therapeutics raised?
Bluejay Therapeutics has disclosed $221.7M raised across 3 rounds.
Where is Bluejay Therapeutics headquartered?
Bluejay Therapeutics is headquartered in San Mateo, US.